Ikena Oncology Acquires Pionyr Immunotherapeutics: Analysts See The Deal As Positive Move
Benzinga
AUGUST 7, 2023
Ikena Oncology Inc (NASDAQ: IKNA ) acquired Pionyr Immunotherapeutics Inc , a privately-held biotechnology company, in an all-stock transaction. per share.
Let's personalize your content